By SquaredTown on February 25, 2026
Conference talk highlights SPOT-Met, perhaps the world's largest in situ multiomic initiative to-date in colorectal cancer; the company also showcases platform validation data, 1,300-gene plex capability, and in situ sequencing of FFPE samples (Direct-Seq™). ORLANDO, Fla., Feb. 25, 2026...